• 1
    Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep 2008; 56:1120.
  • 2
    Statistics Canada. Leading causes of death in Canada. 2010.
  • 3
    Roger V, Go Alan S, Lloyd-Jones D et al. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation 2010; 121:e46215.
  • 4
    Adams HP, Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38:16551711.
  • 5
    del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, on behalf of the American Heart Association, Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40:29452948.
  • 6
    Lansberg MG, O'Donnell MJ, Khatri P et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2012; 141(Suppl.):e601S636.
  • 7
    Lee M, Hong K, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke 2010; 41:932937.
  • 8
    Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006; 37:922928.
  • 9
    Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2009; (4):000213.
  • 10
    Lisboa RC, Jovanovic BD, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002; 33:28662871.
  • 11
    Rha J, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38:967973.
  • 12
    Fields JD, Khatri P, Nesbit GM et al. Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion. J Neurointerv Surg 2011; 3:151155.
  • 13
    Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. Am J Neuroradiol 2001; 22:352358.
  • 14
    van Swieten J, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604607.
  • 15
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:15811588.
  • 16
    Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration, 2011.
  • 17
    Poncyljusz W, Falkowski A, Kojder I et al. Treatment of acute ischemic brain infarction with the assistance of local intraarterial thrombolysis with recombinant tissue-type plasminogen activator. Acta Radiol 2007; 48:774780.
  • 18
    Zhang B, Sun X, Li M et al. Intra-arterial vs intra-venous thrombolysis for anterior cerebral occlusion. Can J Neurol Sci 2010; 37:240244.
  • 19
    Sugiura S, Iwaisako K, Toyota S, Takimoto H. Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset. Am J Neuroradiol 2008; 29:10611066.
  • 20
    Broderick JP. The Interventional Management of Stroke (IMS) II study. Stroke 2007; 38:21272135.
  • 21
    Peeters A. Intra-arterial thrombolysis in the carotid territory. Acta Chir Belg 2004; 104:4243.
  • 22
    Pancioli A, Kothari R. Thrombolytic therapy for acute ischemic stroke. Air Med J 1999; 18:5661.
  • 23
    Gorich J, Kleiser B. Intraarterial fibrinolysis in internal carotid artery and basilar artery occlusions. Rontgenpraxis 1998; 51:363368.
  • 24
    Lang W, Domanovits H, Gorzer H, Germann P, Gatterbauer E, Segall B. Thrombolysis in acute ischemic stroke. Acta Anaesthesiol Scand Suppl 1997; 111:3437.
  • 25
    Jansen O, Von Kummer R, Forsting M, Hacke W, Sartor K. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. Am J Neuroradiol 1995; 16:19771986.
  • 26
    Farkas J, Budzik R, Huang-Hellinger F et al. Intra-arterial thrombolysis in hyperacute stroke. Stroke 1999; 30:264.
  • 27
    Lylyk P, Ferrario A, Ceratto R. Local intraarterial fibrinolysis for acute stroke. J Neurol Sci 1997; 150(Suppl.):S12.
  • 28
    Mattle HP, Schroth G, Arnold M et al. Intraarterial thrombolysis with urokinase in acute ischemic stroke. J Neurol Sci 2005; 238(Suppl. 1):S417.
  • 29
    Saver JL, Kidwell CS, Starkman S et al. Combined intravenous and intraarterial tissue plasminogen activator for acute ischemic stroke: recanalization, safety, and early clinical outcome. Neurology 2001; 56(Suppl. 3):A149150.
  • 30
    Willig V, Hacke W. Thrombolysis of acute stroke with tissue plasminogen activator (rt-PA). Dtsch Med Wochenschr 1996; 121:A810.
  • 31
    Misra V, Barreto AD, Arora R et al. Paradoxical responses to combined intravenous and intra-arterial therapy versus endovascular therapy alone in patients with acute ICA or MCA ischemic stroke. Neurology 2009; 72(Suppl. 3):A277278.
  • 32
    Wechsler LR, Jungreis CA, Massaro LM et al. Long term follow up of patients treated with intraarterial urokinase for acute stroke. Stroke 1998; 29:303.
  • 33
    Jovin TG, Gupta R, Liebeskind DS et al. Imaging based intraarterial treatment for acute anterior circulation ischemic stroke due to intracranial large vessel occlusion beyond 8 hours from symptoms onset multicenter experience. Neurology 2009; 72(Suppl. 3):A2.
  • 34
    Toma N, Taki W, Nakahara I, Sakai N, Murao K, Kawaguchi K. Local intra-arterial thrombolysis for acute ischemic stroke. Fibrinolysis Proteolysis 2000; 14(Suppl. 1):14.
  • 35
    Popiela TJ, Urbanik A, Slowik A. Results of thrombolyses procedures in acute ischemic cerebral stroke realized in Krakow 2004–2007 – Grant Ministry of Science and Information. Przegl Lek 2010; 67:284288.
  • 36
    Kim D, Ford GA, Kidwell CS et al. Intra-arterial thrombolysis for acute stroke in elderly patients. Neurology 2003; 60(Suppl. 1):A428429.
  • 37
    Tomsick T, Broderick J, Carrozella J et al. Revascularization results in the interventional management of stroke II trial. Am J Neuroradiol 2008; 29:582587.
  • 38
    Vaishnav A, Sen S, Verro P, Hariharan S. Long-term outcome of intraarterial tissue plasminogen activator (IA tPA) in acute ischemic stroke 3–6 hours from symptom onset. Neurology 2000; 54(Suppl. 3):A65.
  • 39
    Suarez JI, Zaidat OO, Qureshi AI et al. Intraarterial thrombolysis for patients with ischemic stroke presenting after three hours of symptom onset. Neurology 2001; 56(Suppl. 3):A437.
  • 40
    Kirmani JF, Notestine MA, Slivka AP. Intraarterial thrombolysis for acute stroke in the elderly. Neurology 2001; 56(Suppl. 3):A437.
  • 41
    Dong SW. Urokinase used for intra-arterial and intravenous thrombolysis for acute cerebral infarction: a clinical comparison study. 4th International Conference on Research Advances in Cerebrovascular Disease 2003;179181.
  • 42
    Kandil MR, Farweez HM, Aziz A, Ahmed MA. Evaluation of intraarterial urokinase therapy in acute stroke. J Neurol Sci 2001; 187(Suppl. 1):S256.
  • 43
    Ciccone A, Valvassori L, Ponzio M et al. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg 2010; 2:7479.
  • 44
    del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in acute cerebral thromboembolism. Stroke 1998; 29:411.
  • 45
    Ducrocq X, Bracard S, Taillandier L et al. Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke: randomised study of 27 patients. J Neuroradiol 2005; 32:2632.
  • 46
    Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282:20032011.
  • 47
    Macleod MR, Davis SM, Mitchell PJ et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005; 20:1217.
  • 48
    Ogawa A, Mori E, Minematsu K et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007; 38:26332639.
  • 49
    Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol 1989; 46:660662.
  • 50
    Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768774.
  • 51
    Lees KR, Bluhmki E, Von Kummer R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:16951703.
  • 52
    Ciccone A, Valvassori L, Nichelatti M, SYNTHESIS Expansion investigators. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke. Int J Stroke 2011; 6:259265.